Neuronetics Inc (STIM) - News Archive

Neuronetics Enhances Team with Inducement Grants Amid Strategic Growth InitiativesNeuronetics, Inc. (NASDAQ: STIM), a prominent player in the medical technology landscape, has recently announced an inducement grant in a...

In a strategic move aimed at bolstering its financial position, Neuronetics, Inc. (NASDAQ: STIM) has announced an underwritten public offering of its common stock, a decision that was made public on February 6, 2025. Th...

Neuronetics Strengthens Workforce with Inducement Grants Under NASDAQ Rule 5635(c)(4) A Strategic Move to Enhance Talent Acquisition Malvern, PA, December 18, 2024 Neuronetics, Inc. (NASDAQ: STIM), a pioneering commerci...

In a significant development for the mental health industry, Neuronetics, Inc. (NASDAQ: STIM) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) have announced the successful completion of a strategic acquisition that promises to...

Health Care Service Corporation Expands TMS Coverage for Adolescents: A Ray of Hope in Mental Health Amid Challenging ROI for Neuronetics Inc. In a landmark decision that aims to expand access to innovative mental healt...

In a significant shift towards improving mental health care, recent developments from BlueCross BlueShield of North Carolina and Louisiana Medicaid have expanded coverage for Transcranial Magnetic Stimulation (TMS) ther...

Revolutionizing Mental Health Care: NeuroStar s Commitment to Patient-Centric Solutions In a groundbreaking advancement for mental health care, NeuroStar, a leader in transcranial magnetic stimulation (TMS) therapy, has...

On August 12, 2024, a significant development in the mental health sector caught the attention of investors and industry experts alike. Neuronetics, Inc. (NASDAQ: STIM), a leading company in the medical equipment and su...

Neuronetics, a leading medical technology company specializing in creating innovative solutions for patients with neurohealth disorders, recently announced the issuance of Restricted Stock Units (RSUs) as inducement awa...

In an era marked by increasing mental health concerns among adolescents, a significant partnership has emerged between NeuroStar and This Is My Brave, aimed at amplifying awareness and resources for teen mental health....

In a recent announcement, Neuronetics, Inc. (NASDAQ: STIM) revealed that it has entered into a debt facility of up to $90 million with Perceptive Advisors LLC. This senior secured credit facility will provide Neuronetic...

BlueCross BlueShield of Michigan and Cambia Health Solutions Expand TMS Access for Adolescents with Depression Post-FDA Clearance In a pivotal move aimed at addressing the rising mental health challenges faced by adoles...

Revolutionizing Mental Health Care: NeuroStar Launches Nationwide Provider Program, Sets Unprecedented Standards In a landmark move that promises to elevate the standards of mental health care across the nation, NeuroSt...

Neuronetics, Inc. Grants Inducement Awards to Non-Executive Employees: A Positive Step for Shareholders and the CompanyMALVERN, Pa., March 27, 2024 - Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology compan...

NeuroStar Advanced Therapy: Revolutionizing Adolescent Depression Treatment AccessibilityNeuroStar Advanced Therapy, a groundbreaking treatment for depression utilizing transcranial magnetic stimulation (TMS), has recen...

Neuronetics Partners with Transformations Care Network to Expand Availability of NeuroStar TMS Equipment Neuronetics, a medical technology company specializing in products for neurohealth disorders, has recently announc...

Neuronetics, a leading medical technology company, has recently introduced the latest iteration of its TrakStar Patient Data Management System. This innovative system is poised to revolutionize the workflow efficiencies...

The landscape of mental health treatment is changing at an unprecedented pace, and at the heart of this transformation is a big change from Lucet Health, which is set to massively improve accessibility to Transcranial M...

Technological Advances Streamline and Enhance MDD Treatment: NeuroStar TMS Receives Expanded Regulatory Approval in JapanIn recent news, Neuronetics Inc. has experienced a staggering 42.96% increase in shares following...

In a recent press release, Neuronetics, Inc., a leading medical technology company specializing in improving the quality of life for patients with neurohealth disorders, announced the granting of inducement awards to fo...